Company: FLDDW
Filing Date: 2025-01-14
Form Type: S-4/A
Source: 0001213900-25-003167
Chunk: 238

Company: Fold Holdings, Inc.
Filing Date: 2025-01-14
Form: S-4/A
Chunk 238
---
 “— Interests of Certain Persons in the Merger”below. However, the Emerald Board concluded that (i) these interests were disclosed in the IPO prospectus and/or are included in this proxy statement/prospectus, (ii) these disparate interests would exist with respect to a business combination with any target company, (iii) Emerald stockholders will have the opportunity to redeem their public shares in connection with the Merger and (iv) shares of Emerald Common Stock held by its officers, directors and other initial stockholders are subject to transfer restrictions following the Merger. See the section entitled “The Merger Agreement — Additional Agreements”for a description of these transfer restrictions. Interests of Emerald’s Directors and Officers in the Business Combination In considering the recommendation of the Emerald Board in favor of approval of the Business Combination, it should be noted that Emerald’s directors and officers have interests in the Business Combination that are different from, or in addition to, your interests as an Emerald Stockholder. These interests include, among other things: •If Emerald is unable to complete its initial business combination by the Extension Deadline, it will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining Emerald stockholders and the Emerald Board, liquidate and dissolve, subject in each case to Emerald’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless if Emerald fails to complete our initial business combination by the Extension Deadline. The Sponsor purchased the founder shares prior to Emerald’s IPO for an aggregate purchase price of $25,000. In accordance with the terms of the 2021 Letter Agreement and the Sponsor Share Restriction Agreement, upon the Closing, approximately 5.3million of such founder shares will be subject to transfer restrictions that will lift for one -thirdof the shares when the closing share price of New Fold’s Common Stock exceeds $12.00 for 20 out of any 30 consecutive trading days, one -thirdof the shares upon the earlier of (a)(x) in the event that Emerald and Fold raise $50million or more as of the Closing, one year following the Closing, and (y) in the event that Emerald and Fold raise less than $50million as